The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
75 years of opioid research: the exciting but vain quest for the Holy Grail
Open accessAbstract
Over the 75‐year lifetime of the British Pharmacological Society there has been an enormous expansion in our understanding of how opioid drugs act on the nervous system, with much of this effort aimed at developing powerful analgesic drugs devoid of the side effects associated with morphine – the Holy Grail of opioid research. At the molecular and cellular level multiple opioid receptors have been cloned and characterised, their potential for oligomerisation determined, a large family of endogenous opioid agonists has been discovered, multiple second messengers identified and our understanding of the adaptive changes to prolonged exposure to opioid drugs (tolerance and physical dependence) enhanced. In addition, we now have greater understanding of the processes by which opioids produce the euphoria that gives rise to the intense craving for these drugs in opioid addicts. In this article, we review the historical pathway of opioid research that has led to our current state of knowledge. British Journal of Pharmacology(2006)147, S153–S162. doi:10.1038/sj.bjp.0706435
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485 · cited 1×
“…of the d -receptor followed the discovery of the first endogenous opioid receptor ligands, [Met]- and [Leu]- enkephalin (Hughes et al ., 1975), when it was shown that their pattern of agonist activity in vitro differed from that of the prototypical opioid ligands (Lord et al ., 1977).”
A potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Williams, J. T., Christie, M. J., & Manzoni, O. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.299 · Cited by 848
U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander, P. F., Lahti, R. A., & Ludens, J. H. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33422-1 · Cited by 805
A proposal for the classification of sigma binding sites
Quirion, R., Bowen, W. D., Itzhak, Y., Junien, J. L., Musacchio, J., Rothman, R. B., Tsung-Ping, S., Tam, S. W., & Taylor, D. P. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90030-a · Cited by 755
Waldhoer, M., Bartlett, S. E., & Whistler, J. L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073940 · Cited by 740
G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology
Milligan, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000497 · Cited by 474
CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN
KOSTERLITZ, H. W., PATERSON, S. J., & ROBSON, L. E. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb08749.x · Cited by 422
Self-citationGoldstein, A., Fischli, W., Lowney, L. I., Hunkapiller, M., & Hood, L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7219 · Cited by 399
The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQ
Henderson, G., & McKnight, A. T. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90645-3 · Cited by 331
Self-citationOpioids: cellular mechanisms of tolerance and physical dependence
Bailey, C. P., & Connor, M. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.012 · Cited by 285
Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking
Devi, L. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01799-5 · Cited by 282
Synaptic plasticity and drug addiction
Jones, S., & Bonci, A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.011 · Cited by 245
Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgesics
Feldman, P. L., James, M. K., Brackeen, M. F., Bilotta, J. M., Schuster, S. V., Lahey, A. P., Lutz, M. W., Johnson, M. R., & Leighton, H. J. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a041 · Cited by 194
δ-Opioid receptor subtypes and cross-talk with μ-receptors
Traynor, J. R., & Elliott, J. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90068-u · Cited by 189
Selectivity of Ligands for Opioid Receptors
Corbett, A. D., Paterson, S. J., & Kosterlitz, H. W. (1993) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-77460-7_26 · Cited by 184
Self-citationAnalgesic effectiveness of the narcotic agonist‐antagonists.
Rw, H. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb04704.x · Cited by 140
Molecular Biology of Opioid Analgesia
Pasternak, G. W. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.01.011 · Cited by 140
THE MECHANISM OF ACTION OF NARCOTIC ANALGESICS IN THE GUINEA‐PIG ILEUM
North, R. A., & Tonini, M. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07546.x · Cited by 136
History and development of mixed opioid agonists, partial agonists and antagonists.
Martin, W. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb04700.x · Cited by 134
Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitis
Eisenach, J. C., Carpenter, R., & Curry, R. S. (2002) · Pain · doi:10.1016/s0304-3959(02)00259-2 · Cited by 124
Delvaux, M. M., Beck, A., Jacob, J., Bouzamondo, H., Weber, F. T., & Frexinos, J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01922.x · Cited by 102
Bailey, C. P., Kelly, E., & Henderson, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.004747 · Cited by 96
Self-citationMachelska, H., Pflüger, M., Weber, W., Piranvisseh-Völk, M., Daubert, J. D., DeHaven, R. N., & Stein, C. (1999) · PubMed · Cited by 93
Analgesic Efficacy of Enadoline Versus Placebo or Morphine in Postsurgical Pain
Pande, A. C., Pyke, R. E., Greiner, M., Wideman, G. L., Benjamin, R., & Pierce, M. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619050-00009 · Cited by 91
Naltrexone, opiate addiction, and endorphins
Gold, M. S., Dackis, C. A., Pottash, A. L. C., Sternbach, H. A., Annitto, W. J., Martin, D., & Dackis, M. P. (1982) · Medicinal Research Reviews · doi:10.1002/med.2610020302 · Cited by 89
Bagley, E. E., Gerke, M. B., Vaughan, C. W., Hack, S. P., & Christie, M. J. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.049 · Cited by 77
Behavioral Effects of d-Opioid Receptor Agonists: Potential Antidepressants?
Broom, D. C., Jutkiewicz, E. M., Rice, K. C., Traynor, J. R., & Woods, J. H. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.90.1 · Cited by 66
Analgesic Efficacy of the κ-Receptor Agonist, Enadoline, in Dental Surgery Pain
Pande, A. C., Pyke, R. E., Greiner, M., Cooper, S. A., Benjamin, R., & Pierce, M. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619010-00009 · Cited by 61
Subtypes of the κ-opioid receptor: fact or fiction?
Traynor, J. R. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90074-6 · Cited by 61
Peripheral Effects of the κ-Opioid Agonist EMD 61753 on Pain and Inflammation in Rats and Humans
Machelska, H., Pflüger, M., Weber, W., Piranvisseh-Völk, M., Daubert, J. D., DeHaven, R. N., & Stein, C. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34907-9 · Cited by 47
Opioid elevation of intracellular free calcium: Possible mechanisms and physiological relevance
Samways, D. S. K., & Henderson, G. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.005 · Cited by 39
Self-citationELECTROPHYSIOLOGY ANALYSIS OF OPIOD ACHON IN THE CENTRAL NERVOUS SYSTEM
Henderson, G. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071792 · Cited by 39
Self-citation
Cited by
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Self-citationThomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 756
Basic opioid pharmacology: an update
Pathan, H., & Williams, J. (2012) · British Journal of Pain · doi:10.1177/2049463712438493 · Cited by 671
Opioids and the treatment of chronic pain: Controversies, current status, and future directions.
Rosenblum, A., Marsch, L. A., Joseph, H., & Portenoy, R. K. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0013628 · Cited by 643
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Metadata
- Authors
- Corbett, A. D., Henderson, G., McKnight, A. T., & Paterson, S. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S153-62
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1655590724
- Cited by
- 358
- References
- 34
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.